Amy Gahman Email

Associate Director Quality Assurance . Origin Biosciences

Current Roles

Employees:
7
Revenue:
$1.1M
About
Origin Biosciences, a subsidiary of BridgeBio Pharma, is a biotechnology company focused treatment for Molybdenum Cofactor Deficiency (MoCD). Origin is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment for MoCD to market as quickly as possible.
Origin Biosciences Address
421 Kipling St
Palo Alto, CA
Origin Biosciences Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.